Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00583791

Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder

Heart Septal Defects, Ventricular Clinical Trial

Official title:
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder

Clinical Trial Summary

The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.

Clinical Trial Description

The objective of this feasibility study is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00583791
Study type Interventional
Source Abbott Medical Devices
Contact
Status Completed
Phase N/A
Start date July 2000
Completion date November 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT00390702 - Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System N/A
Completed NCT01480908 - Right Bundle Branch Block After Surgical Closure of Ventricular Septal Defect N/A
Completed NCT00199771 - Hypertonic Saline Dextran in Pediatric Cardiac Surgery Phase 2
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Completed NCT00005546 - Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease N/A
Completed NCT00005322 - Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease N/A
Recruiting NCT00173186 - Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect N/A
Withdrawn NCT01825369 - Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow Phase 1
Completed NCT02361008 - A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect N/A
Terminated NCT00113698 - Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation Phase 3
Completed NCT00000470 - Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Phase 3
Recruiting NCT00006272 - Study of Energy Expenditure in Infants With Ventricular Septal Defects N/A